Protagenic Therapeutics, Inc. (PTIX)

OTCMKTS · Delayed Price · Currency is USD

1.190

-0.010 (-0.83%)

At close: Sep 1, 2026

Protagenic Therapeutics Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Operating Income	-4.26	-4.5	-2.59
Net Income	5.46	1.37	-3.59
Earnings Per Share	2.94	0.59	-0.67
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Cash & Investments	0.57	1.51	0.01
Total Debt	-	-	2.45
Net Cash (Debt)	0.57	1.51	-2.43
Net Cash Growth	580.43%	-	-
Net Cash Per Share	0.30	0.65	-0.45

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Operating Cash Flow	-2	-2.81	-1.77
Capital Expenditures	-0	-0	-
Free Cash Flow	-2	-2.81	-1.77
Free Cash Flow Growth	-	-	-

Valuation

Fiscal Year	Current	FY 2026	FY 2025
Period Ending	Sep '26 Sep 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
PE Ratio	0.40	0.90	-